The rewards of age
Nature Neuroscience
March 25, 2013
Giving older adults the dopamine precursor drug levodopa (L-DOPA) can reduce age related abnormalities in reward-based decision making, according to a study published online this week in Nature Neuroscience.
As some people age, their ability to use information about the likelihood of rewards to make decisions degrades. Rumana Chowdhury and colleagues showed that this change in decision-making was accompanied by changes in brain activity associated with reward expectations and connectivity between the brain areas that encode reward expectation signals. Some of the signals between these brain areas are carried by the neurotransmitter dopamine. The authors found that when they gave underperforming older human adults a dose of a drug that increases dopamine levels in the brain, their sensitivity to rewards improved.
doi: 10.1038/nn.3364
Research highlights
-
Dec 1
Neurodegenerative disease: Two blood molecules may predict Alzheimer’s disease developmentNature Aging
-
Nov 27
Archaeology: Neanderthal thumbs better adapted to holding tools with handlesScientific Reports
-
Nov 26
Evolution: Ancient bird sticks its big beak into the evolutionary recordNature
-
Nov 26
Metabolism: Link between SARS-CoV-2 infection and cholesterol hints at COVID-19 treatment possibilitiesNature Metabolism
-
Nov 25
Zoology: Mineral armour discovered in insectsNature Communications
-
Nov 25
Stem cells: Modelling SARS-CoV-2 lung infection in a dishNature
